Our objective is to define the molecular basis by which membrane glycoproteins are directionally transported to specific cellular locations. These investigations will be carried out using viral glycoproteins which are transported to different plasma membrane domains on surfaces of polarized epithelial cells. To identify sorting signals responsible for the directional transport of glycoproteins, we will analyze the effects of specific modifications and sequence substitutions on determining the cellular location of the resulting molecules. These studies will be carried out with viral glycoproteins which exhibit distinct orientations and transmembrane topology: the gp70/p15E glycoprotein of murine leukemia viruses, a bitopic membrane glycoprotein with a cleaved signal sequence that is anchored by hydrophobic residues near the C-terminus of the molecule, and the gPr-gag glycoprotein which is likely to be anchored to membranes in the opposite orientation. In order to characterize the intracellular transport pathway of MuLV glycoproteins, we will use specific antisera to identify transport vesicles involved in movement of glycoproteins from the Golgi complex to the plasma membrane. We will determine whether the two MuLV-encoded glycoproteins gp70/p15E and gPr-gag are present in the same population of transport vesicles and whether they are associated with one another on the plasma membrane. To further define the viral components which are involved in determining the maturation site of retroviruses in epithelial cells, we will investigate the site of virus assembly and release in cells which produce viral cores in the absence of viral glycoproteins, and determine the effects of supplementing these cells with viral glycoproteins directed to either the apical or basolateral membranes. In addition to providing a better understanding of basic cellular processes, the proposed studies should contribute to our knowledge concerning the pathogenesis of viral infections by elucidating the mechanisms by which viral components are targeted to particular locations.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA018611-19
Application #
2086713
Study Section
Virology Study Section (VR)
Project Start
1978-06-01
Project End
1996-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
19
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Emory University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Seth, Shaguna; Vincent, Annelet; Compans, R W (2003) Activation of fusion by the SER virus F protein: a low-pH-dependent paramyxovirus entry process. J Virol 77:6520-7
Plemper, Richard K; Lakdawala, Ami S; Gernert, Kim M et al. (2003) Structural features of paramyxovirus F protein required for fusion initiation. Biochemistry 42:6645-55
Seth, Shaguna; Vincent, Annelet; Compans, R W (2003) Mutations in the cytoplasmic domain of a paramyxovirus fusion glycoprotein rescue syncytium formation and eliminate the hemagglutinin-neuraminidase protein requirement for membrane fusion. J Virol 77:167-78
Spiropoulou, C F; Goldsmith, C S; Shoemaker, T R et al. (2003) Sin Nombre virus glycoprotein trafficking. Virology 308:48-63
Plemper, Richard K; Compans, Richard W (2003) Mutations in the putative HR-C region of the measles virus F2 glycoprotein modulate syncytium formation. J Virol 77:4181-90
Li, Min; Yang, Chinglai; Tong, Suxiang et al. (2002) Palmitoylation of the murine leukemia virus envelope protein is critical for lipid raft association and surface expression. J Virol 76:11845-52
Tong, S; Li, M; Vincent, A et al. (2002) Regulation of fusion activity by the cytoplasmic domain of a paramyxovirus F protein. Virology 301:322-333
Li, M; Yang, C; Compans, R W (2001) Mutations in the cytoplasmic tail of murine leukemia virus envelope protein suppress fusion inhibition by R peptide. J Virol 75:2337-44
Tong, S; Yi, F; Martin, A et al. (2001) Three membrane-proximal amino acids in the human parainfluenza type 2 (HPIV 2) F protein are critical for fusogenic activity. Virology 280:52-61
Yao, Q; Compans, R W (2000) Filamentous particle formation by human parainfluenza virus type 2. J Gen Virol 81:1305-12

Showing the most recent 10 out of 44 publications